FDA Approves Zyn Nicotine Pouches for Reduced-Risk Marketing
The U.S. Food and Drug Administration (FDA) has cleared Philip Morris-owned Zyn nicotine pouches to be marketed as a less harmful alternative to traditional cigarettes. This landmark regulatory victory for the tobacco giant occurs amid a broader political shift under the Trump administration to loosen restrictions on smoke-free nicotine alternatives.
